883292-60-2

Upstream product

• 883292-58-8 (2S,3S,4S,5S,6S)-5,7-Bis-(tert-butyl-dimethyl-silanyloxy)-2,4,6-trimethyl-heptane-1,3-diol 
• 2186-92-7 p-Anisaldehyde dimethyl acetal 
• 565228-87-7 [[3-(2R,3R)-4R]-3-(3-(tert-butyldimethylsilyloxy)-2,4-dimethyl-1-oxopent-4-enyl)-4-(phenylmethyl)]-2-oxazolidinone 
• 303727-95-9 (2R,3S,4S)-3-[(tert-butyldimethylsilanyl)oxy]-5-hydroxy-2,4-dimethylpentanoic acid methoxymethyl amide 
• 444105-66-2 (3R,4S,5S)-4-[(tert-butyldimethylsilanyl)oxy]-3,5-dimethyltetrahydropyran-2-one 
• 186885-60-9 [[3-(2R,3R)-4R]-3-(3-hydroxy-2,4-dimethyl-1-oxopent-4-enyl)-4-(phenylmethyl)]-2-oxazolidinone 
• 443761-81-7 (2R,3S,4S)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2,4-dimethyl-pentanal 
• 883292-54-4 (E)-(4S,5R,6S)-5,7-Bis-(tert-butyl-dimethyl-silanyloxy)-4,6-dimethyl-hept-2-enoic acid ethyl ester 
• 883292-56-6 {(2R,3R)-3-[(1S,2S,3S)-2,4-Bis-(tert-butyl-dimethyl-silanyloxy)-1,3-dimethyl-butyl]-oxiranyl}-methanol 
• 936637-19-3 (2R,3S,4S)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2,4-dimethyl-pentanoic acid methoxy-methyl-amide 

Downstream Products

• 870773-92-5 (2S,3S,6R,7R,8S,9S,10S)-1,9,11-Tris-(tert-butyl-dimethyl-silanyloxy)-3-hydroxy-7-(4-methoxy-benzyloxy)-2,6,8,10-tetramethyl-undecan-5-one 
• 870773-87-8 (3R,4R,5S,6S,7S)-6,8-Bis-(tert-butyl-dimethyl-silanyloxy)-4-(4-methoxy-benzyloxy)-3,5,7-trimethyl-octan-2-one 
• 883292-62-4 (2R,3R,4S,5S,6S)-5,7-Bis-(tert-butyl-dimethyl-silanyloxy)-3-(4-methoxy-benzyloxy)-2,4,6-trimethyl-heptanal 

Relevant academic research and scientific papers

Studies on the total synthesis of sanglifehrin A: Stereoselective synthesis of the C(29)-C(39) fragment

A highly stereoselective synthesis of the C(29)-C(39) fragment of the potent immunosuppressant sanglifehrin A has been accomplished by a sequence involving 16 steps (18% overall yield) from N-propionyloxazolidinone 9. Key steps are a diastereoselective hy